ClinicalTrials.Veeva

Menu

Assessing the Effectiveness of Screening, Brief Intervention, and Referral to Treatment (SBIRT) With Personalized Feedback Intervention to Reduce Polysubstance Impaired Driving in Young Adults Aged 18-30 (ADAPT)

University of Washington logo

University of Washington

Status

Not yet enrolling

Conditions

Impaired Driving

Treatments

Behavioral: Personalize Feedback Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT07368894
U01CE003725 (U.S. NIH Grant/Contract)
Project 7744 (Other Grant/Funding Number)
STUDY00023076

Details and patient eligibility

About

The current study is assessing the effects of receiving Screening, Brief Intervention and Referral to Treatment alone versus also receiving a brief online personalized intervention on impaired driving behaviors among Washington State young adults aged 18-30.

Full description

The current project is inviting young adult aged 18-30 in Washington State who screen at moderate or moderate to high risk or who report impaired driving during Screening, Brief Intervention and Referral to Treatment. Consented young adults would be randomized to receive a brief online personalized intervention or waitlist control and be assessed at enrollment and 3 months later. A selection of participants will be assessed at 6 months.

Enrollment

600 estimated patients

Sex

All

Ages

18 to 30 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged 18-30 at enrollment
  • Received Screening, Brief Intervention, and Referral to Treatment (SBIRT) in the past 3 month
  • Through SBIRT screened at moderate or moderate-to-high risk based on substance use OR reported any impaired driving the past 6 months
  • Lives in Washington State
  • Received a study information card from an SBIRT provider
  • Consents to having Zip Code use for analyses
  • Consents to randomization to receive brief online personalized intervention or waitlist control

Exclusion criteria

  • Not meeting eligibility criteria
  • Inability to confirm participant's identity, residency, or date received SBIRT.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

600 participants in 2 patient groups

Waitlist control
Active Comparator group
Description:
Individuals will have received SBIRT but will be on a waitlist to receive the brief personalized intervention for 3 months after baseline assessment.
Treatment:
Behavioral: Personalize Feedback Intervention
Active Intervention
Experimental group
Description:
Participants will have received SBIRT and receive the brief online personalized intervention immediately after baseline assessment.
Treatment:
Behavioral: Personalize Feedback Intervention

Trial contacts and locations

0

Loading...

Central trial contact

Ari Lisitza, MS; Brittney Hultgren, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems